Deciphex is exhibiting at Arab Health 2022 in Dubai, one of the world's leading healthcare and health technologies events. The Middle East is a market of 250m people and one where access to the best clinical expertise is highly valued. Diagnexia provides rapid access to remote subspeciality pathology consults, through the use of digital pathology and provides clinicians in the region with a much faster and cost efficient approach to seeking expert second opinions on difficult clinical pathology cases.
Donal O’Shea, CEO of Deciphex says
“The Middle East is a region of strategic interest for our Diagnexia remote pathology consult business, we are delighted to be able to exhibit at Arab Health with the support of Enterprise Ireland on the Ireland Pavillion.”
Visit Deciphex and hear more about their Diagnexia remote pathology consult service at the Ireland Pavillion, Hall 3.
Deciphex is exhibiting at Arab Health 2022 in Dubai, one of the world's leading healthcare and health technologies events. The Middle East is a market of 250m people and one where access to the best clinical expertise is highly valued. Diagnexia provides rapid access to remote subspeciality pathology consults, through the use of digital pathology and provides clinicians in the region with a much faster and cost efficient approach to seeking expert second opinions on difficult clinical pathology cases.
Donal O’Shea, CEO of Deciphex says
“The Middle East is a region of strategic interest for our Diagnexia remote pathology consult business, we are delighted to be able to exhibit at Arab Health with the support of Enterprise Ireland on the Ireland Pavillion.”
Visit Deciphex and hear more about their Diagnexia remote pathology consult service at the Ireland Pavillion, Hall 3.